29 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35108055 | Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. | 2022 Feb 4 | 1 |
2 | 33513824 | Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy. | 2021 Jan 27 | 1 |
3 | 32373203 | Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. | 2020 Mar | 2 |
4 | 31200653 | Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties. | 2019 Jun 14 | 1 |
5 | 26824987 | Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. | 2016 Feb 23 | 2 |
6 | 25755052 | In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. | 2015 May | 4 |
7 | 26504822 | Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity. | 2015 | 1 |
8 | 20435919 | Cilastatin attenuates cisplatin-induced proximal tubular cell damage. | 2010 Aug | 1 |
9 | 9453453 | Identification of urinary dipeptidase as the released form of renal dipeptidase. | 1997 | 1 |
10 | 8776942 | Recent advances in the chemistry and biology of carbapenem antibiotics. | 1996 | 1 |
11 | 8899192 | Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis. | 1996 Oct | 1 |
12 | 7492120 | The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA. | 1995 Jul | 1 |
13 | 7648757 | Meropenem clinical pharmacokinetics. | 1995 Apr | 3 |
14 | 2139939 | [Clinical pharmacokinetics of an imipenem-cilastatin combination]. | 1990 Apr 4 | 1 |
15 | 2768222 | Purification and characterization of human microsomal dipeptidase. | 1989 Jun | 4 |
16 | 3331041 | Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections. | 1987 | 1 |
17 | 3480361 | [Effects of cilastatin sodium, an inhibitor of dehydropeptidase-I, on human urinary peptide excretion. Patients with renal insufficiency]. | 1987 Sep | 1 |
18 | 3463788 | [Imipenem/cilastatin sodium in the treatment of obstetric and gynecologic infections]. | 1986 May | 1 |
19 | 3465739 | High-performance liquid chromatographic determination of cilastatin in biological fluids. | 1986 Oct 31 | 1 |
20 | 3546249 | An overview of the pharmacology of imipenem/cilastatin. | 1986 Dec | 1 |
21 | 3859242 | Pharmacokinetics of imipenem-cilastatin in neonates. | 1985 Apr | 1 |
22 | 3863219 | Pharmacokinetics of imipenem and cilastatin in volunteers. | 1985 Jul-Aug | 2 |
23 | 3863619 | Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D4-dipeptidase. | 1985 Sep 16 | 2 |
24 | 3867330 | Cilastatin does not alter superoxide dismutase activity. | 1985 Nov | 1 |
25 | 3901213 | Open trial of imipenem/cilastatin therapy for serious bacterial infections. | 1985 Jul-Aug | 1 |
26 | 3980311 | Primaxin in the treatment of acute bacterial pneumonia in adults. | 1985 Feb | 2 |
27 | 6595962 | Disposition of radiolabeled imipenem and cilastatin in normal human volunteers. | 1984 Nov | 1 |
28 | 6573157 | Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. | 1983 Feb | 1 |
29 | 6607914 | In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. | 1983 Dec | 4 |